SALINE-FILLED BREAST IMPLANT AVAILABILITY SHOULD BE LIMITED
This article was originally published in The Gray Sheet
SALINE-FILLED BREAST IMPLANT AVAILABILITY SHOULD BE LIMITED to controlled trials, Public Citizen's Health Research Group says in an Aug. 4 petition to FDA. "Pending a final decision by the FDA regarding whether they are sufficiently safe and effective," HRG argues, "any further use of the devices should be limited" to a three-stage clinical protocol similar to that currently in place for silicone gel-filled breast implants.
You may also be interested in...
Officials from the US Food and Drug Administration cited their reasons for refusing to review new applications for companies with unresolved data integrity failures.
However, Vaccinex sees possible efficacy for SEMA4D inhibition in later-stage Huntington’s as well as Alzheimer’s disease. Pepinemab is also being studied with Keytruda in head-and-neck cancer.
In last year’s acquisition, Bristol Myers Squibb agreed to pay Celgene investors another $9 per share based on three approvals, including idecabtagene vicleucel (bb2121) by 30 March 2021.